FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹4.48 Cr | ₹4.14 Cr | ₹3.84 Cr | ₹1.43 Cr | ₹1.38 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of FREDUN PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹4.48 Cr |
| Mar2024 | ₹4.14 Cr |
| Mar2023 | ₹3.84 Cr |
| Mar2022 | ₹1.43 Cr |
| Mar2021 | ₹1.38 Cr |
How is Deferred Tax Assets / Liabilities of FREDUN PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.48 Cr | 8.39 | |
| Mar2024 | ₹4.14 Cr | 7.65 | |
| Mar2023 | ₹3.84 Cr | 168.55 | |
| Mar2022 | ₹1.43 Cr | 3.92 | |
| Mar2021 | ₹1.38 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹866.9 Cr | -6.5% | -16.5% | 125.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | -6.5% |
-16.5% |
125.6% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses